Improving Outcomes Assessment in Chronic GVHD

Active, not recruitingOBSERVATIONAL
Enrollment

601

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

May 31, 2017

Study Completion Date

February 28, 2027

Conditions
Chronic Graft Versus Host Disease
Trial Locations (9)

10065

Memorial Sloan Kettering, New York

33612

H. Lee Moffitt Cancer Center, Tampa

37232

Vanderbilt University, Nashville

53226

Medical College of Wisconsin, Milwaukee

55455

University of Minnesota, Minneapolis

63110

Washington University School of Medicine, St Louis

94305

Stanford University, Stanford

98109

Fred Hutchinson Cancer Research Center, Seattle

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

University of Minnesota

OTHER

collaborator

Stanford University

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Vanderbilt University

OTHER

collaborator

Medical College of Wisconsin

OTHER

collaborator

Washington University School of Medicine

OTHER

collaborator

H. Lee Moffitt Cancer Center and Research Institute

OTHER

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00637689 - Improving Outcomes Assessment in Chronic GVHD | Biotech Hunter | Biotech Hunter